Shayan Mohammadmoradi: Excited to Co-Chair the 2028 Hemostasis Gordon Research Seminar
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared a post on LinkedIn:
”What a fantastic week at the 2026 Hemostasis GRS/C! The science, discussions, collaborations, and friendships made this an unforgettable experience.
I am especially excited to share that my good friend and colleague Ana Sachetto and I have been selected as the incoming Co-Chairs of the 2028 Hemostasis Gordon Research Seminar!
We are honored by the opportunity and already looking forward to creating an engaging, inclusive, and memorable program for the next generation of our field.
A huge thank you to the Chairs and Vice Chairs of the 2026 GRC for creating such a phenomenal program.
See you in 2028 and stay tuned!”
Stay updated with Hemostasis Today.
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI
-
Nov 7, 2026, 13:50Edward Lee Carter: Is Aspirin Monotherapy Sufficient After Watchman Implantation?
-
Nov 7, 2026, 13:40Leticia Leal: Preventing Blood Clots During Long Flights